Introduction {#Sec1}
============

The global increase of obesity and associated comorbidities urges for effective and satisfying treatments \[[@CR31]\]. Obesity is the ultimate result of an imbalance between energy intake and energy expenditure (EE) \[[@CR26]\]. Weight loss can be achieved by reducing energy intake and/or increasing EE. Research has been focussing on specific food components, which may have favourable effects on weight-loss, weight-maintenance, and metabolism. One of these specific food components is capsaicin, the pungent principle of hot red pepper. Capsaicin has been reported to have favourable effects on EE, fat oxidation, and appetite control \[[@CR11], [@CR13], [@CR30], [@CR32], [@CR33]\]. The effects of capsaicin on energy and lipid metabolism are associated with an increase in sympathetic nervous system activity \[[@CR12], [@CR13], [@CR32], [@CR33]\].

In a recent study we have shown that the satiating effect of capsaicin is present after gastrointestinal exposure, and is even more profound after the combination of sensory and gastrointestinal exposure \[[@CR30]\]. The stimulatory effect of capsaicin is likely due to the involvement of a transient receptor potential vanilloid receptor 1 (TRPV1)-linked mechanism \[[@CR5]\]. Capsaicin-sensitive primary afferent sensory nerves are found in the nerves innervating the whole gastrointestinal tract \[[@CR10], [@CR16], [@CR17]\]. From predominantly animal studies we know that capsaicin may affect gastrointestinal physiology \[[@CR15]\]. Interestingly, capsaicin was found to increase blood flow and secretion in the gastrointestinal tract \[[@CR3], [@CR19], [@CR20], [@CR25]\]. Furthermore, capsaicin-sensitive primary afferent sensory nerves have been suggested to be involved in the effects of nutrients on gut-derived hormones, such as cholescystokinin, ghrelin, peptide YY (PYY), glucagon-like peptide 1 (GLP-1), and gastric motility and emptying in rats \[[@CR1], [@CR6], [@CR7], [@CR21]\]. Intestinal TRPV1-positive, and thus capsaicin binding, nerves may play a role in the observed effects of capsaicin. Possibly through effects on local blood flow or through intrinsic neural pathways, which both may affect the exposure of the gut to nutrients (through intestinal motility), and the hormone release of adjacent hormone releasing intestinal cells \[[@CR15]\]. Few studies have looked at the effects of capsaicin on gastrointestinal physiology, i.e., gastric emptying and isolated intestinal muscle strip relaxation, in humans \[[@CR8], [@CR18]\]. Whether capsaicin affects the secretion of gut-derived hormones, and whether this is associated with the satiating effects of capsaicin is unknown. Therefore, the aim of this study was to test the acute effects of a lunch containing capsaicin on gut-derived hormones (GLP-1, ghrelin, and PYY). In addition, we investigated the acute effects of a meal containing capsaicin on EE, substrate oxidation and satiety at lunch in the postprandial state. We hypothesised that a single meal containing capsaicin compared with a single control meal might increase satiety, diet-induced thermogenesis (DIT), plasma PYY and GLP-1 concentrations, and fat oxidation, and decrease plasma ghrelin concentrations, and respiratory quotient (RQ).

Subjects and methods {#Sec2}
====================

Subjects {#Sec3}
--------

Thirty healthy subjects (19 women and 11 men) with a body mass index (BMI in kg/m^2^) of 20--30 and aged 18--60 years were recruited by advertisements in local newspapers and on notice boards at Maastricht University. All subjects underwent a medical screening, and all were in good health, non-smokers, not using medication, and at most moderate alcohol users (less than 10 units a week). Eating behaviour was assessed using a validated Dutch translation of the TFEQ. Cognitive restrained and unrestrained eating behaviour (Factor 1), emotional eating and disinhibition (Factor 2), and the subjective feeling of hunger (Factor 3) were scored \[[@CR27]\]. The baseline characteristics of the subjects are presented in Table [1](#Tab1){ref-type="table"}. A written informed consent was obtained from all the participants. The Medical Ethics Committee of the Academic Hospital in Maastricht approved the study.Table 1Subject characteristics (*n* = 30)ValueAge (years)31 ± 14Body weight (kg)72 ± 12Height (m)1.73 ± 0.09BMI (kg/m^2^)23.8 ± 2.8Body fat (%)25.6 ± 8.8Dietary restraint^a^4.3 ± 2.6All values are mean ± SD^a^Factor 1 (dietary restraint) of the Three-Factor Eating Questionnaire was used

Experimental sessions {#Sec4}
---------------------

The study had a single blind, randomised, crossover design. The two tests were conducted at least 1 week apart. Subjects underwent two indirect calorimetry tests for the measurement of EE and substrate oxidation. On the morning before the test (8:00 a.m.), the subjects received a subject-specific breakfast (milk-based drink with fruit and cereals called "Drinkontbijt", Campina, Woerden, Netherlands), which provided 15% of each subject's individual daily energy requirements. Subject-specific daily energy requirements were calculated based on basal metabolic rate (BMR), which was calculated with the equation of Harris and Benedict \[[@CR9]\]. The BMR was multiplied by an activity index of 1.5. After the breakfast, subjects were not allowed to eat or drink during the morning except water and one cup of coffee or tea without milk or sugar. One hour before the test lunch was served (11:00 a.m.), baseline EE and substrate oxidation were measured by means of an open-circuit, ventilated-hood system with subjects lying supine for at least 30 min. At 12:00 a.m. the subjects received a lunch, which they consumed within 30 min of one of two randomly assigned treatments: control lunch or the lunch supplemented with 1,030 mg red pepper equivalent to 80,000 Scoville Heat Units (SHU) of capsaicin (Cayenne, Solaray, Park City, UT, USA). This dose of capsaicin was chosen based on our experiences concerning the highest tolerable dose in a previous study. Both lunches provided 35% of each subject's individual daily energy requirements, provided 10% of energy from protein, 60% of energy from carbohydrate, 30% of energy from fat, and consisted of pasta (Technical University of Budapest, Department of Biochemistry and Food Technology, Budapest, Hungary), sausages (Matforsk, Ås, Norway), and tomato sauce (Heinz, Elst, The Netherlands). The spiciness of the meal with capsaicin was well tolerated by all subjects. Post-lunch EE and substrate oxidation were measured for 210 min after ingestion of the lunch.

Energy expenditure and substrate oxidation {#Sec5}
------------------------------------------

On the test days, baseline and post-lunch EE and substrate oxidation were measured with an open-circuit, ventilated-hood system with the subjects lying supine \[[@CR24]\]. Gas analysis was performed by a paramagnetic O~2~ analyser (OmniCal type 1155B; Crowborough, Sussex, UK) and an IR CO~2~ analyser (OmniCal type 1520/1507). EE was calculated using Brouwer's formula \[[@CR2]\]. The RQ was calculated as CO~2~ produced/O~2~ consumed. Carbohydrate, fat, and protein oxidation were calculated from the measurements of oxygen consumption, carbon dioxide production, and urinary nitrogen excretion by using the formula of Brouwer \[[@CR2]\]. Urine samples were collected from the first void after the start of the test day (11:00 a.m.) until the last void on the test day (4:00 pm). Subjects voided their bladder before the start of the test day (before 11:00 a.m.). Samples were collected in containers with 10 ml H~2~SO~4~ to prevent nitrogen loss through evaporation. Volume and nitrogen concentration were measured, the latter with a nitrogen analyser (CHN-O-Rapid; Heraeus, Hanau, Germany).

Blood sampling {#Sec6}
--------------

One hour before the lunch was served (11:00 a.m.), a polytetrafluoroethylene catheter was placed in the antecubital vein for blood sampling. During each test day, five blood samples (at 0, 45, 60, 120, and 180 min after lunch) were taken for measurement of plasma ghrelin, GLP-1, and PYY concentrations. Blood samples were collected in tubes kept on ice and containing EDTA to prevent clotting. Plasma was obtained by centrifugation (4 °C, 3,000 rpm, 10 min) and stored at −80 °C until analysed. Plasma concentrations of active ghrelin were measured by RIA (Linco Research Inc., St. Charles, Missouri, USA). Plasma active ghrelin concentrations were measured in acidified plasma with 50 μl of 1 N HCl and addition of 10 μl of phenylmethylsulfonyl fluoride (PMSF) per 1 ml of plasma. Sensitivity of the RIA assay was 7.8 pg/ml and the difference between duplicate results of a sample was less than 10% CV. The specificity for human ghrelin was 100%. Plasma active GLP-1 samples were analysed using ELISA (EGLP-35K; Linco Research Inc., St. Charles, Missouri, USA). Plasma active GLP-1 concentrations were measured in plasma after addition of 10 μl DPP-IV inhibitor per millilitre of blood. Sensitivity of the ELISA assay was 2 pM, and the difference between duplicate results of a sample was less than 10% CV. The specificity for active GLP-1 was 100%. PYY was measured with a specific and sensitive radioimmunoassay, which measures both the full length (PYY1-36) and the fragment (PYY3-36) (Linco Research Inc., St. Charles, MO, USA). Plasma PYY concentrations were measured in plasma after addition of Aprotinin at a final concentration of 500 KIU/mL of blood. Sensitivity of the PYY RIA assay was 10 pg/ml and the difference between duplicate results of a sample was less than 10% CV. The specificity for human PYY was 100%.

Appetite profile {#Sec7}
----------------

Appetite profile was measured with the use of anchored 100-mm visual analogue scales (VAS). During each test-day these questionnaires were completed just before the lunch (*t* = 0), and at 30, 60, 90, 120, 150, 180 and 240 min. The questions were, "How hungry are you?" and "How satiated are you?" and were anchored by "not at all" and "very."

Body composition {#Sec8}
----------------

Body composition was measured by using the deuterium dilution technique. A ^2^H~2~O dilution was used to measure total body water (TBW). The subjects were asked to collect a urine sample in the evening just before drinking the deuterium-enriched water solution. After ingestion of this solution, the subjects went to bed and no additional consumption was allowed for this period. Ten hours after drinking the water solution, another urine sample was collected. The dilution of the deuterium isotope is a measure of the TBW of the subject. Deuterium was measured in the urine samples with an isotope ratio mass spectrometer (VG-Isogas Aqua Sira; VG Isogas, Middlewich, England). TBW was obtained by dividing the measured deuterium dilution space by 1.04. Fat-free mass (FFM) was calculated by dividing TBW by the hydration factor 0.73. Fat mass (FM) was determined as BW---FFM \[[@CR23], [@CR28], [@CR29]\].

Statistical analysis {#Sec9}
--------------------

Data are presented as mean ± SD unless otherwise indicated. Differences between means were analysed by Student's *t* test. Regression analyses were performed to determine the relations between selected variables. All statistical tests were performed by using Statview SE Graphics software (version 4.5; Abacus Concepts Inc., Berkeley, CA, USA).

Results {#Sec10}
=======

Energy expenditure and substrate oxidation {#Sec11}
------------------------------------------

Baseline EE did not differ before the CAPS lunch (4.87 ± 0.72 kJ/min) and control lunch (4.77 ± 0.81 kJ/min). The increase in post-lunch after the CAPS lunch (0.62 ± 0.28 kJ/min) did not differ from the control lunch (0.72 ± 0.22 kJ/min). Total post-lunch EE above baseline EE over 210 min after the CAPS lunch (133.7 ± 58.3 kJ) did not differ from the control lunch (151.34 ± 47.09 kJ). Total post-lunch EE above baseline EE over 210 min as percentage of the energy content of the lunch after the CAPS lunch (3.9 ± 1.4%) did not differ from the control lunch (4.3 ± 1.2%) either.

Respiratory quotient did not differ between the CAPS (0.85 ± 0.05) and the control (0.86 ± 0.04) treatments. Non-protein RQ did not differ between the CAPS (0.86 ± 0.05) and control (0.87 ± 0.05) treatments. Substrate oxidation was not different in the CAPS condition from the control condition (protein oxidation CAPS: 15.2 ± 4.7 g, control: 16.9 ± 6.2 g, carbohydrate oxidation CAPS: 34.4 ± 12.8 g, control: 37.3 ± 12.4 g, fat oxidation CAPS: 15.2 ± 7.2 g, control: 13.2 ± 6.4 g).

Blood parameters {#Sec12}
----------------

The plasma hormone concentrations did not differ between the two treatments at baseline. Changes in hormone concentrations in response to the lunches are expressed as the change from baseline. Plasma GLP-1 responses were higher at *t* = 45 min in the CAPS condition than in the control condition (*p* \< 0.05, Fig. [1](#Fig1){ref-type="fig"}). The AUC of plasma GLP-1 response did not differ after the CAPS lunch (221 ± 91 pM h) and the control lunch (191 ± 94 pM h).Fig. 1Mean (±SEM) changes in GLP-1 plasma concentrations from baseline for the capsaicin (*n* = 30) and control (*n* = 30) lunch. \* *p* \< 0.05

Plasma active ghrelin response tended to be lower at *t* = 45 min in the CAPS condition compared to in the control condition (*p* \< 0.07, Fig. [2](#Fig2){ref-type="fig"}). The AUC of plasma active ghrelin response did not differ after the CAPS lunch (−1,869 ± 2,281 pg/ml h) and the control lunch (−1,334 ± 1,886 pg/ml h).Fig. 2Mean (±SEM) changes in active ghrelin plasma concentrations from baseline for the capsaicin (*n* = 30) and control (*n* = 30) lunch

Plasma PYY responses did not differ at any of the measured time points after the CAPS and control lunch (Fig. [3](#Fig3){ref-type="fig"}). The AUC of plasma PYY response did not differ after the CAPS lunch (139 ± 1,107 pg/ml h) and the control lunch (259 ± 880 pg/ml h).Fig. 3Mean (±SEM) changes in PYY plasma concentrations from baseline for the capsaicin (*n* = 30) and control (*n* = 30) lunch

Appetite profile {#Sec13}
----------------

Satiety VAS scores did not differ at any of the measured time points between the CAPS and control lunch (Fig. [4](#Fig4){ref-type="fig"}). AUC satiety VAS score did not differ after the CAPS and control lunch (Fig. [4](#Fig4){ref-type="fig"}). Satiety VAS scores were not correlated with plasma GLP-1, ghrelin, and PYY concentrations at any time-point or when expressed as AUC.Fig. 4Mean (±SEM) satiety ratings measured with the use of an anchored 100-mm visual analogue scale for the capsaicin (*n* = 30) and control (*n* = 30) lunch

Discussion {#Sec14}
==========

In the present study, a single meal with 1,030 mg red pepper equivalent to 80,000 SHU of capsaicin in the postprandial phase, did not affect subjective feelings of satiety, DIT, substrate oxidation, and plasma PYY responses for a period of 3 h as compared to a control meal. Over a short period of time, i.e., 15 min, a single meal with capsaicin in the postprandial phase, significantly increased plasma GLP-1 concentrations and tended to decrease plasma ghrelin concentrations as compared to a control meal.

In a study by Yoshioka, the addition of 30 mg capsaicin to a high-fat breakfast and a high-carbohydrate breakfast significantly decreased prospective food consumption at lunch \[[@CR32]\]. Furthermore, desire to eat as well as hunger significantly decreased after the high-fat breakfast with capsaicin. An important difference between the latter study and our study, which may explain the differences in satiety related outcomes, is that we tested the addition of capsaicin at lunch.

Although physiologically important, the postprandial state may have masked the differences in feelings of satiety after the CAPS compared to the control meal. In a recent study we observed that subjective feelings of satiety were significantly higher after capsaicin supplementation over 2 days compared to placebo, which suggests that the effect of capsaicin on subjective feelings of satiety may need to build up \[[@CR30]\].

In the present study, we observed no differences in DIT between the CAPS and the control condition. We hypothesised that DIT would be higher after the CAPS meal compared to after the control meal. Capsaicin is perceived as a hot substance \[[@CR22]\]. Because the ingestion of hot substances can lead to an increase in body temperature, feedback mechanisms are activated to lower body temperature, such as blood vessel dilatation and sweating. The greater heat loss, due to blood vessel dilatation and sweating, after capsaicin ingestion may contribute to a higher DIT. Again, in the present study the postprandial state may have masked the effect of CAPS on DIT. The previously observed small and short effect of capsaicin on EE, in the post-absorptive state, may have been too small to be distinguished during the postprandial state \[[@CR33]\].

We observed no differences in substrate oxidation between the CAPS and control condition. Capsaicin has been reported to increase carbohydrate oxidation over the short term (after one breakfast exposure) and to increase fat oxidation over the long term (in fasted state after 3 months exposure) \[[@CR14], [@CR33]\].

Fifteen minutes after the CAPS lunch, plasma GLP-1 concentrations were significantly increased, and there was a trend for plasma ghrelin concentrations to be decreased compared to after the control lunch. Capsaicin was found to increase gastric emptying in a study by Debreceni et al. \[[@CR4]\]. In the present study, increased gastric emptying after the CAPS lunch may have resulted in earlier exposure of the small intestine to nutrients, which subsequently may have led to a stronger effect on gut-derived hormones over a short period of time. As far as we know, no other human studies have looked at the effects of CAPS supplementation on gut-derived hormones. Therefore, more research is needed to investigate the mechanisms behind the possible effects of capsaicin on gut-derived hormones.

In comparison with other studies we observed no acute effects of CAPS on satiety, DIT, substrate oxidation, and plasma PYY responses for a period of 3 h. Over a short period of time, i.e., 15 min, a single meal with capsaicin in the postprandial phase, significantly increased plasma GLP-1 concentrations and tended to decrease plasma ghrelin concentrations.

The present results should be interpreted with caution, because this study was conducted at lunch in the postprandial state. Most studies on single meals containing CAPS have been conducted at breakfast in the post-absorptive state, which make them difficult to compare with the present study.

The data of the present paper indicate that the CAPS supplementation of one meal in a postprandial state has no effects on substrate utilisation, appetite feelings and PYY responses. However, the observed effects of CAPS on GLP-1 and ghrelin responses warrant more intensive research on the possible eating behaviour-related effects of capsaicin.
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